Update in bridging anticoagulation

Journal of Thrombosis and Thrombolysis

Volumn 31, Issue 3, 2011, Pages 259-264

  Kaatz, Scott ^a   Paje, David ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Anticoagulation; Bridging; Interruption; Low molecular weight heparin; Vitamin K antagonist

Indexed keywords

ANTIVITAMIN K; ENOXAPARIN; HEMOSTATIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ARTERIAL THROMBOEMBOLISM; BLEEDING; BLEEDING DISORDER; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CONFERENCE PAPER; DENTAL SURGERY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG WITHDRAWAL; EYE SURGERY; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; PATIENT CODING; PATIENT SAFETY; PATIENT SELECTION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; RECURRENT DISEASE; RISK FACTOR; SKIN SURGERY; SURGICAL RISK; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOEMBOLISM; VITAMIN K; WARFARIN;

EID: 79958151320     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0571-z     Document Type: Conference Paper

References (22)

1. Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, Ansell J (2008) The perioperative management of antithrombotic therapy: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6 Suppl):299S-339S
2. Kearon C, Hirsh J (1997) Management of anticoagulation before and after elective surgery. N Engl J Med 336(21):1506-1511. doi:10.1056/ NEJM199705223362107
3. Dunn AS, Turpie AG (2003) Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 163(8):901-908. doi:10.1001/archinte.163.8.901163/8/901 (Pubitemid 36522737)
4. Jaffer AK, Brotman DJ, Bash LD, Mahmood SK, Lott B, White RH (2010) Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals. Am J Med 123(2):141-150
5. Douketis JD, Crowther MA, Cherian SS (2000) Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey. Can J Cardiol 16(3):326-330 (Pubitemid 30197746)
6. Douketis JD, Crowther MA, Cherian SS, Kearon CB (1999) Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. Chest 116(5):1240-1246 (Pubitemid 29535974)
7. Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othman M, Hylek EM (2008) Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 168(1):63-69. doi:10.1001/archinternmed.2007.23
8. Blacker DJ, Wijdicks EF, McClelland RL (2003) Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology 61(7):964-968 (Pubitemid 37248654)
9. Kaatz S, Douketis JD, Zhou H, Gage BF, White RH (2010) Risk of stroke after surgery in patients with and without chronic atrial fibrillation. J Thromb Haemost. doi:10.1111/j.1538-7836.2010.03781.x
10. Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146(12):857-867 (Pubitemid 351650486)
11. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation. JAMA 285(22):2864-2870 (Pubitemid 32537350)
12. Cannegieter SC, Rosendaal FR, Briet E (1994) Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89(2):635-641 (Pubitemid 24056190)
13. Hering D, Piper C, Bergemann R, Hillenbach C, Dahm M, Huth C, Horstkotte D (2005) Thromboembolic and bleeding complications following St Jude medical valve replacement: results of the German experience with low-intensity anticoagulation study. Chest 127(1):53-59. doi:10.1378/chest.127.1.53 (Pubitemid 41724555)
14. Salem DN, O'Gara PT, Madias C, Pauker SG (2008) Valvular and structural heart disease: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6):593S-629S. doi:10.1378/chest.08- 0724
15. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW (2008) Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6 Suppl):381S-453S. doi:10.1378/chest.08-0656
16. McBane RD, Wysokinski WE, Daniels PR, Litin SC, Slusser J, Hodge DO, Dowling NF, Heit JA (2010) Periprocedural anticoagulation management of patients with venous thromboembolism. Arterioscler Thromb Vasc Biol 30(3):442-448. doi:10.1161/ATVBAHA.109.199406
17. Dunn AS, Spyropoulos AC, Turpie AG (2007) Bridging therapy in patients on long-term oral anticoagulants who require surgery: the prospective peri-operative enoxaparin cohort trial (PROSPECT). J Thromb Haemost 5(11):2211-2218. doi:10.1111/j.1538-7836.2007.02729.x (Pubitemid 47617873)
18. Douketis JD, Johnson JA, Turpie AG (2004) Low-molecularweight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 164(12):1319-1326. doi:10.1001/archinte.164.12.1319164/12/1319 (Pubitemid 38828883)
19. Kovacs MJ, Kearon C, Rodger M, Anderson DR, Turpie AG, Bates SM, Desjardins L, Douketis J, Kahn SR, Solymoss S, Wells PS (2004) Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 110(12):1658-1663. doi:10.1161/01.CIR.0000142859.77578.C901.CIR.0000142859. 77578.C9 (Pubitemid 39297990)
20. Douketis JD, Woods K, Foster GA, Crowther MA (2005) Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery. Thromb Haemost 94(3):528-531. doi:10.1160/TH05-01-0064 (Pubitemid 41300847)
21. O'Donnell MJ, Kearon C, Johnson J, Robinson M, Zondag M, Turpie I, Turpie AG (2007) Brief communication: preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin. Ann Intern Med 146(3):184-187 (Pubitemid 351650631)
22. Marquie C, De Geeter G, Klug D, Kouakam C, Brigadeau F, Jabourek O, Trillot N, Lacroix D, Kacet S (2006) Post-operative use of heparin increases morbidity of pacemaker implantation. Europace 8(4):283-287. doi:10.1093/ europace/eul011 (Pubitemid 43905736)